Last synced on 20 December 2024 at 11:05 pm

Fludeoxyglucose F18-Guided Radiation Therapy System

Page Type
Product Code
Definition
A fludeoxyglucose F18-guided radiation therapy system is a device that combines the functionality of an emission computed tomography detection system and a linear accelerator. The device is intended for use with approved fludeoxyglucose F18. The emission computed tomography detection system acquires images of positron-emitting fludeoxyglucose F18 for the purpose of guiding the delivery of megavoltage X-rays for oncologic treatment with radiation therapy using an FDA cleared, authorized, or approved linear accelerator.
Physical State
Combination linear accelerator and PET imaging system with software to allow for fludeoxyglucose F18-guided radiation therapy.
Technical Method
Input from fludeoxyglucose F18 PET images acquired using this device acts a biological fiducial marker in order to guide oncologic radiation therapy treatment.
Target Area
Fludeoxyglucose F18-avid tumors.
Regulation Medical Specialty
Radiology
Review Panel
Radiology
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
892.5060
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

Product code QVA is linked to regulation 21CFR892.5060, which does not seem to exist yet. It may be pending at the moment.

Fludeoxyglucose F18-Guided Radiation Therapy System

Page Type
Product Code
Definition
A fludeoxyglucose F18-guided radiation therapy system is a device that combines the functionality of an emission computed tomography detection system and a linear accelerator. The device is intended for use with approved fludeoxyglucose F18. The emission computed tomography detection system acquires images of positron-emitting fludeoxyglucose F18 for the purpose of guiding the delivery of megavoltage X-rays for oncologic treatment with radiation therapy using an FDA cleared, authorized, or approved linear accelerator.
Physical State
Combination linear accelerator and PET imaging system with software to allow for fludeoxyglucose F18-guided radiation therapy.
Technical Method
Input from fludeoxyglucose F18 PET images acquired using this device acts a biological fiducial marker in order to guide oncologic radiation therapy treatment.
Target Area
Fludeoxyglucose F18-avid tumors.
Regulation Medical Specialty
Radiology
Review Panel
Radiology
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
892.5060
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

Product code QVA is linked to regulation 21CFR892.5060, which does not seem to exist yet. It may be pending at the moment.